Outcomes | No.of studies | SamPle size | Heterogeneity(Total) | W(S)MD/RR(95%CI) | P value(Total) | ||||
---|---|---|---|---|---|---|---|---|---|
mPCNL | RIRS | chi2 | df | I2% | P value | ||||
Overall SFR | 17 | 862 | 821 | 42.3 | 16 | 62.1 | 0.01 | 1.08(1.03–1.14) | P = 0.002 |
SFR(stone 1–2 cm) | 11 | 571 | 573 | 28.34 | 10 | 64.7 | 0.002 | 1.09(1.03–1.15) | P = 0.003 |
SFR(stone 2–3 cm) | 3 | 123 | 122 | 4.78 | 2 | 58.2 | 0.092 | 1.19(1.05–1.36) | P = 0.007 |
Operation time | 18 | 887 | 846 | 836.6 | 17 | 98.00% | 0 | -6.82(-15.45, 1.81) | P = 0.122 |
Operation time(2013–2019) | 8 | 341 | 353 | 322.5 | 7 | 97.80% | 0 | -0.65(-16.56, 15.26) | p = 0.936 |
Operation time(2019–2022) | 10 | 546 | 493 | 62.9 | 9 | 85.70% | 0 | -10.85(-16.76,-4.94) | p<0.001 |
Transfusion | 9 | 419 | 420 | 0.78 | 6 | 0 | 0.993 | 5.04(1.62–15.65) | P = 0.005 |
Hospitalization time | 17 | 827 | 786 | 810.5 | 16 | 98 | 0 | 1.01(0.53,1.5) | P<0.001 |
Pain visual analogue score | 7 | 378 | 388 | 81.65 | 6 | 92.7 | 0 | 0.75(0.04–1.46) | P = 0.037 |
Hb drop | 11 | 723 | 667 | 56.4 | 10 | 82.3 | 0 | 0.27(0.14–0.41) | P<0.001 |
Complication ratio | 16 | 832 | 792 | 38.29 | 15 | 60.8 | 0.001 | 1.17(0.82–1.68) | P = 0.39 |
Clavien-Dindo(I-II) | 17 | 857 | 817 | 40.47 | 16 | 60.5 | 0.001 | 1.03(0.74–1.42) | P = 0.88 |
Clavien-Dindo(III) | 12 | 583 | 542 | 8.25 | 7 | 15.2 | 0.311 | 1.89(1.014–3.53) | P = 0.045 |
Cost | 4 | 221 | 183 | 5.18 | 3 | 42 | 0.159 | -0.97(-1.19, -0.76) | P<0.001 |